Early Experience with AngioVac Aspiration in the Pulmonary Arteries

Ramsey Al-Hakim; Jonathan Park; Anshuman Bansal; Scott Genshaft; John M. Moriarty

doi:10.1016/j.jvir.2016.01.012

Early Experience with AngioVac Aspiration in the Pulmonary Arteries

Ramsey Al-Hakim, Jonathan Park, Anshuman Bansal, Scott Genshaft, John M. Moriarty

Research output: Contribution to journal › Article › peer-review

56 Scopus citations

Abstract

Five consecutive cases in which the AngioVac aspiration cannula was used for the management of pulmonary embolism (PE) were retrospectively reviewed. Four cases (80%) presented with massive PE, and two (40%) were technically successful (reduction in Miller index ≥ 5). Four patients (80%) died at a mean of 7.3 days after the procedure, including one death related to right ventricular free wall perforation. Although the AngioVac aspiration cannula has shown clinical promise in a variety of clinical applications, early experience in the pulmonary arteries has shown limited success, and further study and careful patient selection are required.

Original language	English (US)
Pages (from-to)	730-734
Number of pages	5
Journal	Journal of Vascular and Interventional Radiology
Volume	27
Issue number	5
DOIs	https://doi.org/10.1016/j.jvir.2016.01.012
State	Published - May 1 2016

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging
Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.jvir.2016.01.012

Cite this

@article{f46dbb865dfe45e7ad97bdbece25e85d,

title = "Early Experience with AngioVac Aspiration in the Pulmonary Arteries",

abstract = "Five consecutive cases in which the AngioVac aspiration cannula was used for the management of pulmonary embolism (PE) were retrospectively reviewed. Four cases (80%) presented with massive PE, and two (40%) were technically successful (reduction in Miller index ≥ 5). Four patients (80%) died at a mean of 7.3 days after the procedure, including one death related to right ventricular free wall perforation. Although the AngioVac aspiration cannula has shown clinical promise in a variety of clinical applications, early experience in the pulmonary arteries has shown limited success, and further study and careful patient selection are required.",

author = "Ramsey Al-Hakim and Jonathan Park and Anshuman Bansal and Scott Genshaft and Moriarty, {John M.}",

note = "Publisher Copyright: {\textcopyright} 2016 SIR.",

year = "2016",

month = may,

day = "1",

doi = "10.1016/j.jvir.2016.01.012",

language = "English (US)",

volume = "27",

pages = "730--734",

journal = "Journal of Vascular and Interventional Radiology",

issn = "1051-0443",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - Early Experience with AngioVac Aspiration in the Pulmonary Arteries

AU - Al-Hakim, Ramsey

AU - Park, Jonathan

AU - Bansal, Anshuman

AU - Genshaft, Scott

AU - Moriarty, John M.

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Five consecutive cases in which the AngioVac aspiration cannula was used for the management of pulmonary embolism (PE) were retrospectively reviewed. Four cases (80%) presented with massive PE, and two (40%) were technically successful (reduction in Miller index ≥ 5). Four patients (80%) died at a mean of 7.3 days after the procedure, including one death related to right ventricular free wall perforation. Although the AngioVac aspiration cannula has shown clinical promise in a variety of clinical applications, early experience in the pulmonary arteries has shown limited success, and further study and careful patient selection are required.

AB - Five consecutive cases in which the AngioVac aspiration cannula was used for the management of pulmonary embolism (PE) were retrospectively reviewed. Four cases (80%) presented with massive PE, and two (40%) were technically successful (reduction in Miller index ≥ 5). Four patients (80%) died at a mean of 7.3 days after the procedure, including one death related to right ventricular free wall perforation. Although the AngioVac aspiration cannula has shown clinical promise in a variety of clinical applications, early experience in the pulmonary arteries has shown limited success, and further study and careful patient selection are required.

UR - http://www.scopus.com/inward/record.url?scp=84964335911&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964335911&partnerID=8YFLogxK

U2 - 10.1016/j.jvir.2016.01.012

DO - 10.1016/j.jvir.2016.01.012

M3 - Article

C2 - 27106647

AN - SCOPUS:84964335911

SN - 1051-0443

VL - 27

SP - 730

EP - 734

JO - Journal of Vascular and Interventional Radiology

JF - Journal of Vascular and Interventional Radiology

IS - 5

ER -

Early Experience with AngioVac Aspiration in the Pulmonary Arteries

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this